Displaying items by tag: division of pulmonary allergy and critical care medicine

Cure HHT has named the HHT Clinic at UAB Hospital a Center of Excellence. Only hospitals equipped with the proper personnel, expertise, commitment and resources to provide comprehensive evaluation, treatment and education to individuals with HHT and their families receive this designation.
Chronic obstructive pulmonary disease patients with type 2 inflammation saw rapid and sustained improvements in their disease after treatment with the monoclonal antibody dupilumab.
Description of this mechanism offers a promising therapeutic target to limit lung injury and death. Lower respiratory tract infections, including bacterial pneumonia, are the fourth-leading cause of death worldwide, with 120 million to 156 million cases and 1.4 million deaths a year.
Patients suffering from cystic fibrosis often struggle with malnutrition, due to the disease’s impact on the digestive system and the increased energy needs of the body.
Bhatt serves as the medical director of the UAB Pulmonary Function and Exercise Physiology Lab and the UAB Pulmonary Rehabilitation Program.
Basic research in bacteria has led Michael Niederweis and Moon Nahm to 17 U.S. patents and various new technologies with real impacts on the welfare of society.
Sarcoidosis is an inflammatory disease characterized by the formation of granulomas in one or more organs of the body.
The UAB Multidisciplinary Sarcoidosis Clinic is focused on better understanding and treating sarcoidosis, to help patients with serious cases live longer, healthier lives.
Page 1 of 7